Daptomycin-Induced Pulmonary Toxicity: A Case Series

被引：0
作者：
Patel, Yamini I. [1 ]
Natarajan, Sarasija [1 ]
Ramakrishna, Srinivasarao [2 ]
Ochieng, Pius [2 ]
机构：
[1] Wright Ctr Grad Med Educ, Internal Med, Scranton, PA 18505 USA
[2] Geisinger Commonwealth Sch Med, Pulm & Crit Care Med, Scranton, PA USA
来源：
CUREUS JOURNAL OF MEDICAL SCIENCE | 2023年 / 15卷 / 05期
关键词：
antibiotic; bronchoscopy; eosinophilia; hypoxia; fever; pulmonary toxicity; adverse effects of daptomycin; drug induced eosinophilic pneumonia; eosinphilic pneumonia; daptomycin; EOSINOPHILIC PNEUMONIA;
D O I：
10.7759/cureus.39613
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Daptomycin is a bactericidal antibiotic used to treat methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococcus (VRE). Eosinophilic pneumonia is an uncommon but significant adverse effect of daptomycin. We present two patients treated with daptomycin who subsequently developed eosinophilic pneumonia (EP).
引用
收藏
页数：5
相关论文
共 17 条
  • [1] Drug-induced eosinophilic pneumonia A review of 196 case reports
    Bartal, Carmi
    Sagy, Iftach
    Barski, Leonid
    [J]. MEDICINE, 2018, 97 (04)
  • [2] Daptomycin
    Enoch, David A.
    Bygott, Jeanine M.
    Daly, Marie-Louise
    Karas, J. Andreas
    [J]. JOURNAL OF INFECTION, 2007, 55 (03) : 205 - 213
  • [3] Daptomycin-induced Eosinophilic Pneumonia and a Review of the Published Literature
    Higashi, Yoshitsugu
    Nakamura, Shigeki
    Tsuji, Yasuhiro
    Ogami, Chika
    Matsumoto, Kaoru
    Kawago, Koyomi
    Tokui, Kotaro
    Hayashi, Ryuji
    Sakamaki, Ippei
    Yamamoto, Yoshihiro
    [J]. INTERNAL MEDICINE, 2018, 57 (02) : 253 - 258
  • [4] Eosinophilic pneumonia caused by daptomycin: Six cases from two institutions and a review of the literature
    Hirai, Jun
    Hagihara, Mao
    Haranaga, Shusaku
    Kinjo, Takeshi
    Hashioka, Hiroe
    Kato, Hideo
    Sakanashi, Daisuke
    Yamagishi, Yuka
    Mikamo, Hiroshige
    Fujita, Jiro
    [J]. JOURNAL OF INFECTION AND CHEMOTHERAPY, 2017, 23 (04) : 245 - 249
  • [5] Factors Associated with Daptomycin-Induced Eosinophilic Pneumonia
    Ishikawa, Kazuhiro
    Matsuo, Takahiro
    Tsuda, Yasumasa
    Rahman, Mahbubur
    Uehara, Yuki
    Mori, Nobuyoshi
    [J]. ANTIBIOTICS-BASEL, 2022, 11 (02):
  • [6] A Retrospective Study on the Effectiveness and Safety of Vancomycin versus Daptomycin in Hemodialysis Patients
    Kato, Hideo
    Hagihara, Mao
    Kato, Mariko
    Yamagishi, Yuka
    Umemura, Takumi
    Asai, Nobuhiro
    Hirai, Jun
    Iwamoto, Takuya
    Mikamo, Hiroshige
    [J]. ANTIBIOTICS-BASEL, 2022, 11 (06):
  • [7] Eosinophilic Pneumonia in Patients Treated with Daptomycin Review of the Literature and US FDA Adverse Event Reporting System Reports
    Kim, Peter W.
    Sorbello, Alfred F.
    Wassel, Ronald T.
    Pham, Tracy M.
    Tonning, Joseph M.
    Nambiar, Sumathi
    [J]. DRUG SAFETY, 2012, 35 (06) : 447 - 457
  • [8] Acute Eosinophilic Pneumonia Secondary to Daptomycin: A Report of Three Cases
    Miller, Becky A.
    Gray, Alice
    LeBlanc, Thomas W.
    Sexton, Daniel J.
    Martin, Andrew R.
    Slama, Thomas G.
    [J]. CLINICAL INFECTIOUS DISEASES, 2010, 50 (11) : E63 - E68
  • [9] Patel S, 2022, DAPTOMYCIN STATPEARL
  • [10] Seventeen Cases of Daptomycin-Induced Eosinophilic Pneumonia in a Cohort of Patients Treated for Bone and Joint Infections: Proposal for a New Algorithm
    Pham, Truong-Thanh
    Garreau, Romain
    Craighero, Fabien
    Cottin, Vincent
    Ben Said, Benoit
    Goutelle, Sylvain
    Ferry, Tristan
    Lyon Bone Joint Infection Study Grp
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (11):
12